Literature DB >> 27121462

TRIM59 is upregulated and promotes cell proliferation and migration in human osteosarcoma.

Jinqian Liang1, Dan Xing2, Zheng Li1, Jianxiong Shen1, Hong Zhao1, Shugang Li1.   

Abstract

Osteosarcoma is a prevalent type of cancer and has a high metastatic ability, particularly for metastasis to the lungs. Effective treatment strategies have improved, however, the detailed molecular mechanism underlying the onset of this malignancy remains to be fully elucidated. The current study investigated the role of the tripartite motif (TRIM) family protein TRIM59 in osteosarcoma growth and metastasis. It was identified that TRIM59 was overexpressed in clinical osteosarcoma tissues and cultured osteosarcoma cell lines. In addition, the MTT assay demonstrated that in U2OS and MG63 cells, knockdown of TRIM59 by specific siRNA inhibited proliferation, whereas overexpression of TRIM59 promoted cell proliferation. Furthermore, overexpression of TRIM59 significantly increased the U2OS cell migrative and invasive abilities in a Transwell chamber assay. In addition, TRIM59 was able to negatively regulate the protein levels of P53 without significantly affecting the mRNA levels in U2OS and MG63 cells. These data suggest the oncogenic abilities of TRIM59 in osteosarcoma, which promote osteosarcoma cell proliferation, migration and invasion.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27121462     DOI: 10.3892/mmr.2016.5183

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  21 in total

1.  Gene co-expression network analysis for identifying modules and functionally enriched pathways in SCA2.

Authors:  Lance T Pflieger; Warunee Dansithong; Sharan Paul; Daniel R Scoles; Karla P Figueroa; Pratap Meera; Thomas S Otis; Julio C Facelli; Stefan M Pulst
Journal:  Hum Mol Genet       Date:  2017-08-15       Impact factor: 6.150

2.  TRIM59 promotes osteosarcoma progression via activation of STAT3.

Authors:  Guoxing Xu; Zhenjiang Ma; Fei Yang; Yanqiang Bai; Jian Li; Wanglin Luo; Jiangbo Zhong
Journal:  Hum Cell       Date:  2021-10-09       Impact factor: 4.174

Review 3.  TRIM family contribute to tumorigenesis, cancer development, and drug resistance.

Authors:  Ning Huang; Xiaolin Sun; Peng Li; Xin Liu; Xuemei Zhang; Qian Chen; Hong Xin
Journal:  Exp Hematol Oncol       Date:  2022-10-19

4.  TRIM59 Promotes Gliomagenesis by Inhibiting TC45 Dephosphorylation of STAT3.

Authors:  Youzhou Sang; Yanxin Li; Lina Song; Angel A Alvarez; Weiwei Zhang; Deguan Lv; Jianming Tang; Feng Liu; Zhijie Chang; Shigetsugu Hatakeyama; Bo Hu; Shi-Yuan Cheng; Haizhong Feng
Journal:  Cancer Res       Date:  2018-01-31       Impact factor: 12.701

5.  TRIM59 is a novel potential prognostic biomarker in patients with non-small cell lung cancer: A research based on bioinformatics analysis.

Authors:  Ling Hao; Boyu Du; Xueyan Xi
Journal:  Oncol Lett       Date:  2017-06-22       Impact factor: 2.967

6.  TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway.

Authors:  Ye Sun; Bing Ji; Yifei Feng; Yue Zhang; Dongjian Ji; Chunyan Zhu; Sen Wang; Chuan Zhang; Dongsheng Zhang; Yueming Sun
Journal:  Oncol Rep       Date:  2017-05-22       Impact factor: 3.906

7.  Silencing Trim59 inhibits invasion/migration and epithelial-to-mesenchymal transition via TGF-β/Smad2/3 signaling pathway in bladder cancer cells.

Authors:  Wei Chen; Kai Zhao; Chenkui Miao; Aiming Xu; Jianzhong Zhang; Jundong Zhu; Shifeng Su; Zengjun Wang
Journal:  Onco Targets Ther       Date:  2017-03-09       Impact factor: 4.147

Review 8.  Mechanisms of TP53 Pathway Inactivation in Embryonic and Somatic Cells-Relevance for Understanding (Germ Cell) Tumorigenesis.

Authors:  Dennis M Timmerman; Tessa L Remmers; Sanne Hillenius; Leendert H J Looijenga
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

9.  TRIM22 confers poor prognosis and promotes epithelial-mesenchymal transition through regulation of AKT/GSK3β/β-catenin signaling in non-small cell lung cancer.

Authors:  Li Liu; Xiao-Ming Zhou; Fang-Fei Yang; Yuan Miao; Yan Yin; Xue-Jun Hu; Gang Hou; Qiu-Yue Wang; Jian Kang
Journal:  Oncotarget       Date:  2017-07-01

10.  A novel prognostic factor TRIM44 promotes cell proliferation and migration, and inhibits apoptosis in testicular germ cell tumor.

Authors:  Yuta Yamada; Ken-Ichi Takayama; Tetsuya Fujimura; Daisaku Ashikari; Daisuke Obinata; Satoru Takahashi; Kazuhiro Ikeda; Shigenori Kakutani; Tomohiko Urano; Hiroshi Fukuhara; Yukio Homma; Satoshi Inoue
Journal:  Cancer Sci       Date:  2016-12-01       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.